- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02767739
Effects of Physical Activity on Cardiovascular Risk and Quality of Life
A Randomized Community Trial of Physical Activity Intervention in Primary Healthcare to Improve Cardiovascular Risk Factors and Health-Related Quality of Life in Older Adults
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
* Adults users of 4 Primary Health Care Centers in Catalunya.
Exclusion Criteria:
- Previous episode of ischemic heart disease (<6 months).
- Outbreak of arthritis with limited ability to ambulate.
- Lung or heart disease with dyspnea mild-moderate efforts.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Physical, social and cultural activities
Physical Activity: The training program will be supervised by a physical activity specialist and will consiste of two aerobic exercise sessions per week, including walking and stretching exercises after walking. Each session will be 60 minutes and the size of groups will be from 15 to 30 participants. Additionally, participants will receive advice about the health benefits of PA and PHC nurses using different strategies to encourage the adherence of participants to the program. Social and cultural support activities. Activities will include: visits to museums and libraries, cultural exhibitions, tourist attractions and dance lessons. These activities will be performed once a month. |
This intervention included two 60-min aerobic exercise sessions per week.
Each session was supervised by a physical activity specialist and walking and stretching exercises were performed after programmed exercise sessions.
PHC nurses were prepared to advise patients about the health benefits of PA and used different strategies to encourage the adherence of participants to the program.
In addition, social and cultural support activities were included in this intervention program.
These activities were performed once a month and they included: visits to museums and libraries, cultural exhibitions, tourist attractions and dance lessons.
|
|
Sin intervención: Control Group
No intervention.
We will measure the variables at the begining and after 9 months.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Physical activity level
Periodo de tiempo: At the begining of the intervention and after 9 months.
|
It will assess at baseline and final by using the short form of the International Physical Activity Questionnarie (IPAQ-S) validated in the Catalan population.
It provides a self-estimated number of hours dedicated to PA.
The categories are: low, moderate and vigorous physical activity.
IPAQ data will use to measure the total weekly Physical Activity level in metabolic equivalents (METs)/min/week by weighting time spent in each activity intensity level with an estimated metabolic equivalent (MET) energy expenditure
|
At the begining of the intervention and after 9 months.
|
|
Cardiovascular risk.
Periodo de tiempo: At the begining of the intervention and after 9 months
|
All participants will be asked if they have ever been diagnosed of hypertension, type 2 diabetes, dyslipidemia, overweight or obesity.
Blood pressure will be measured with a sphygmomanometer after participants have been sitting quietly for at least five minutes; three recordings will be taken and the average of the second and third readings will be use.
The cardiovascular risk will be calculated for each participant using the REGICOR scale based on Framingham criteria standardized for the Spanish population .
|
At the begining of the intervention and after 9 months
|
|
Biochemical analysis.
Periodo de tiempo: At the begining of the intervention and after 9 months.
|
The biochemical parameters to analyze will be: Triglycerides, total cholesterol, HDL- and LDL-cholesterol; glycated hemoglobin and glucose.
A unique study profile has been created to analyze all these parameters at the Tarraco laboratory (ISO9001:2000 certified ICS Tarragona laboratory).
Blood will be extracted by PHC nurses from the fasting users in the corresponding PCC at 8:00 am.
The same professional will take it to the central laboratory using the standard sample transport procedure between PCC and the central laboratory.
|
At the begining of the intervention and after 9 months.
|
|
Antropometric measurements.
Periodo de tiempo: At the begining of the intervention and after 9 months.
|
Weight (kg) will be measured using a balance scale with the measurement taken to the nearest 0.1 kg.
Height (cm) will be measured using a balance scale with the measurement taken to the nearest 1 cm.
Weight and Height measurements will be then used to calculate the body mass index [BMI: Weight (kg)/ (Height) 2 (m2)].
Waist circumference (WC), will be measured finding the top of their hip bone and the bottom of their ribs.
Threfore, the tape measure will be placed in the middle between these points and wrapped around the waist.
|
At the begining of the intervention and after 9 months.
|
|
Frequency of food consumption
Periodo de tiempo: At the begining of the intervention and after 9 months.
|
We will use a validated food frequency questionnaire to assess food consumption.
Participants will be asked to report the number of times per week or month that certain foods will be consumed (45-items).
Foods will be grouped according to their nutrient composition: dairy (milk, yogurt, dairy desserts, cheese); meat/fish/eggs (red, white, processed meat and cold meat, lean, fatty fish and shellfish); total cereals (rice, pasta, bread, breakfast cereals, legumes -all type-, chocolate, biscuits, pastries and candies); fruits/vegetables (salad, tomatoes; vegetables side dish: aubergine, courgette, mushrooms; green beans, chards, spinaches, fresh fruits and canned fruits); oils and beverages (sweetened beverages, fermented beverages and alcoholic beverages), then the amount of g/day of each item will be calculated from the ECA-REF study's reference values.
|
At the begining of the intervention and after 9 months.
|
|
Health related quality of life
Periodo de tiempo: At the begining of the intervention and after 9 months.
|
It will assess at baseline and final of the intervention with the Spanish version of the 36-item Short Form Health Survey (SF-36).
It consists of 36 items used to measure health status and outcomes from the patient's point of view, including the following 8 health concepts: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, mental health.
Two summary measures, the physical component summary (PCS) and the mental component summary (MCS), are derived from the last 8 health scores.
Participant responses to each item gave a total numerical score which will transform to 0-100 scale, so that a higher score corresponds to a better health status.
|
At the begining of the intervention and after 9 months.
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Arija V, Villalobos F, Pedret R, Vinuesa A, Jovani D, Pascual G, Basora J. Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial. Health Qual Life Outcomes. 2018 Sep 14;16(1):184. doi: 10.1186/s12955-018-1008-6.
- Arija V, Villalobos F, Pedret R, Vinuesa A, Timon M, Basora T, Aguas D, Basora J; Pas-a-Pas research group. Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the "Pas-a-Pas" community intervention trial. BMC Public Health. 2017 Jun 15;17(1):576. doi: 10.1186/s12889-017-4485-3.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- P11/67
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .